Advanced Therapies Journal

Advanced Therapies Journal

Therapeutic Potential of Neural Stem Cells for Regenerating Damaged Neural Pathways: Current Evidence and Future Directions

Reviewers

Author
Mahdieh Ameri Shah Reza
Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
10.22034/atj.2026.253122
Abstract
Neural stem cells (NSCs) represent a promising therapeutic strategy for repairing damaged neural circuits in the central nervous system (CNS). The therapeutic promise of NSCs stems from their dual capacity for sustained self-renewal and differentiation into neurons, astrocytes, and oligodendrocytes, which collectively support the regeneration of injured neural tissue and the recovery of neurological function. Beyond direct cell replacement, NSCs exert powerful paracrine effects through the secretion of neurotrophic factors, cytokines, and extracellular vesicles that modulate inflammation, enhance neuronal survival, and promote axonal regeneration. Increasing evidence indicates that NSC-mediated immunomodulation plays a central role in shifting the post-injury microenvironment from a neurotoxic to a regenerative state, primarily through regulation of microglial polarization and suppression of pro-inflammatory signaling pathways.
In addition, NSCs contribute to neural repair by enhancing synaptic plasticity, supporting remyelination, stabilizing the blood–brain barrier, and facilitating angiogenesis. Accumulating preclinical evidence suggests that both NSC transplantation and the therapeutic application of NSC-derived secretomes lead to significant functional improvement in animal models of spinal cord injury, stroke, and traumatic brain injury. However, clinical translation remains limited by challenges such as poor cell survival, immune rejection, tumorigenic risk, and lack of standardized delivery protocols. Emerging strategies, including gene-edited NSCs, biomaterial scaffolds, and exosome-based cell-free therapies, are being developed to overcome these limitations. Overall, NSCs provide a multifaceted regenerative platform with strong potential for future clinical applications in neurological disorders, although further large-scale clinical studies are essential to validate the long-term safety and efficacy of these therapies.
Keywords
Neural stem cells, CNS regeneration, Neuroplasticity, Immunomodulation
Axonal regeneration
1.Kvistad CE, Kråkenes T, Gavasso S, Bø L. Neural regeneration in the human central nervous system: From understanding the underlying mechanisms to developing treatments. Front Neurol. 2024;15:1398089. doi:10.3389/fneur.2024.1398089.
2.    Punjani N, Deska-Gauthier D, Hachem LD. Neuroplasticity and regeneration after spinal cord injury. N Am Spine Soc J. 2023;15:100235. doi:10.1016/j.xnsj.2023.100235.
3.    Liu H, Wei T, Huang Q, Liu W, Yang Y, Jin Y, et al. The roles, mechanism, and mobilization strategy of endogenous neural stem cells in brain injury. Front Aging Neurosci. 2022;14:924262. doi:10.3389/fnagi.2022.924262.
4.    Zhang Z, Li J, Wang B, Hou C, Liu Q, Wang W, et al. Ubiquitin-specific protease 22 promotes neural stem cell stemness maintenance and adult hippocampal neurogenesis, contributing to cognitive recovery following traumatic brain injury. Neuroscience. 2022;496:219-229. doi:10.1016/j.neuroscience.2022.05.020.
5.    Li J, Luo W, Xiao C, Zhao J, Xiang C, Liu W, et al. Recent advances in endogenous neural stem/progenitor cell manipulation for spinal cord injury repair. Theranostics. 2023;13(12):3966-3987. doi:10.7150/thno.84720.
6.    Li C, Luo Y, Li S. The roles of neural stem cells in myelin regeneration and repair therapy after spinal cord injury. Stem Cell Res Ther. 2024;15:204. doi:10.1186/s13287-024-03820-5.
7.    Rybachuk O, Nesterenko Y, Zhovannyk V. Modern advances in spinal cord regeneration: Hydrogel combined with neural stem cells. Front Pharmacol. 2024;15:1419797. doi:10.3389/fphar.2024.1419797.
8.    Muhammad SA, Abbas AY, Imam MU, Saidu Y, Bilbis LS. Efficacy of stem cell secretome in the treatment of traumatic brain injury: A systematic review and meta-analysis of preclinical studies. Mol Neurobiol. 2022;59(5):2894-2909. doi:10.1007/s12035-022-02763-2.
9.    Xiong Y, Pi W, Zhao W, Shi W, Yan W, Yang H, et al. Roles of cerebrospinal fluid-contacting neurons as potential neural stem cells in the repair and regeneration of spinal cord injuries. Front Cell Dev Biol. 2024;12:1426395. doi:10.3389/fcell.2024.1426395.
10.Gage FH. Adult neurogenesis in mammals. Science. 2019;364(6443):827-828. doi:10.1126/science.aav6885.
11.Assinck P, Duncan GJ, Hilton BJ, Plemel JR, Tetzlaff W. Cell transplantation therapy for spinal cord injury. Nat Neurosci. 2017;20(5):637-647. doi:10.1038/nn.4541.
12.Bonner JF, Steward O. Repair of spinal cord injury with neuronal relays: From fetal grafts to neural stem cells. Brain Res. 2015;1619:115-123. doi:10.1016/j.brainres.2014.10.010.
13.Sirerol-Piquer MS, Morante-Redolat JM, Porlan E. Editorial: Unravelling neural stem cell biology: players and strategies. Front Cell Dev Biol. 2023;11:1206339. doi:10.3389/fcell.2023.1206339. 
14.de Almeida MMA, Goodkey K, Voronova A. Regulation of microglia function by neural stem cells. Front Cell Neurosci. 2023;17:1130205. doi:10.3389/fncel.2023.1130205. 
15.Eşiyok NE, Heide M. The SVZ stem cell niche: components, functions, and in vitro modelling. Front Cell Dev Biol. 2023;11:1332901. doi:10.3389/fcell.2023.1332901. 
16.Murtaj V, Butti E, Martino G, Panina-Bordignon P. Endogenous neural stem cells characterization using omics approaches: current knowledge in health and disease. Front Cell Neurosci. 2023;17:1125785. doi:10.3389/fncel.2023.1125785. 
17.Meng H, Huan Y, Zhang K, Yi X, Meng X, Kang E, et al. Quiescent adult neural stem cells: developmental origin and regulatory mechanisms. Neurosci Bull. 2024;40(9):1353–1363. doi:10.1007/s12264-024-01206-1. 
18.Shi Y, Wang J, Wang Y, Shao Y, Li X. Epigenetic regulation in adult neural stem cells. Front Cell Neurosci. 2024;18:1340400. doi:10.3389/fncel.2024.1340400. 
19.Queiroz LY, Kageyama R, Cimarosti HI. SUMOylation effects on neural stem cells self-renewal, differentiation, and survival. Neurosci Res. 2024;199:1–11. doi:10.1016/j.neures.2023.09.006. 
20.de Almeida MMA, Goodkey K, Voronova A. Neural stem and precursor cells in CNS regeneration and immunomodulation. Front Cell Neurosci. 2023;17:1130205. doi:10.3389/fncel.2023.1130205. 
21.Gage FH. Adult neurogenesis in mammals. Science. 2019;364(6443):827–828. doi:10.1126/science.aav6885. 
22.Kvistad CE, Kråkenes T, Gavasso S, Bø L. Neural regeneration in the human central nervous system: From understanding the underlying mechanisms to developing treatments. Front Neurol. 2024;15:1398089. doi:10.3389/fneur.2024.1398089. 
23.Punjani N, Deska-Gauthier D, Hachem LD. Neuroplasticity and regeneration after spinal cord injury. N Am Spine Soc J. 2023;15:100235. doi:10.1016/j.xnsj.2023.100235. 
24.Li Y, Wang H, Zhang H, et al. Signaling pathways and epigenetic regulation in neural stem cell-mediated neural repair. Front Cell Neurosci. 2023;17:1189420. doi:10.3389/fncel.2023.1189420. 
25.Huang Y, Liu X, Zhang Y, et al. Notch and Wnt signaling in neural stem cell fate regulation and CNS regeneration. Stem Cell Res Ther. 2024;15:112. doi:10.1186/s13287-024-03745-z. 
26.Zhang J, Chen S, Li X, et al. Sonic hedgehog signaling in neural development and regeneration. Neuroscience. 2022;498:120–132. doi:10.1016/j.neuroscience.2022.06.010. 
27.Shi Y, Wang J, Wang Y, et al. Epigenetic regulation in adult neural stem cells. Front Cell Neurosci. 2024;18:1340400. doi:10.3389/fncel.2024.1340400. 
28.Queiroz LY, Kageyama R, Cimarosti HI. SUMOylation and epigenetic control in neural stem cells. Neurosci Res. 2024;199:1–11. doi:10.1016/j.neures.2023.09.006. 
29.Zheng X, Boyer L, Jin M, et al. Metabolic regulation of neural stem cell fate decisions. Nat Metab. 2023;5:845–858. doi:10.1038/s42255-023-00820-1. 
30.Li X, Zhou Y, Guo Y, et al. Neurotrophic factor signaling in neural repair and regeneration. Prog Neurobiol. 2022;214:102269. doi:10.1016/j.pneurobio.2022.102269. 
31.Doeppner TR, Hermann DM. Extracellular vesicles in neural stem cell-mediated brain repair. Trends Neurosci. 2021;44(10):842–856. doi:10.1016/j.tins.2021.06.005. 
32.Xin H, Katakowski M, Wang F, et al. MicroRNA-containing exosomes in neural repair. J Cereb Blood Flow Metab. 2020;40(10):2060–2071. doi:10.1177/0271678X20925168. 
33.de Almeida MMA, Goodkey K, Voronova A. Neural stem cells regulate microglial activation in CNS injury. Front Cell Neurosci. 2023;17:1130205. doi:10.3389/fncel.2023.1130205. 
34.Silver J, Schwab ME, Popovich PG. Central nervous system regeneration failure: role of inhibitory environment. Nat Rev Neurosci. 2015;16:133–143. doi:10.1038/nrn3856. 
35.Anderson MA, Burda JE, Ren Y, et al. Astrocyte scar formation and CNS regeneration. Nature. 2016;532:195–200. doi:10.1038/nature17623. 
36.Tran AP, Warren PM, Silver J. The biology of CNS scar formation and axon regeneration. Nat Rev Neurosci. 2018;19:31–44. doi:10.1038/nrn.2017.140. 
37.Rybachuk O, Nesterenko Y, Zhovannyk V. Hydrogel-based neural stem cell therapy for spinal cord regeneration. Front Pharmacol. 2024;15:1419797. doi:10.3389/fphar.2024.1419797. 
38.Li S, He X, Chen L, et al. Genetically engineered neural stem cells for enhanced CNS repair. Stem Cell Res Ther. 2023;14:215. doi:10.1186/s13287-023-03345-8. 
39.Li J, Zhang Y, Wang H, et al. Neuroinflammation and stem cell immunomodulation in CNS repair. Front Immunol. 2023;14:1183321. doi:10.3389/fimmu.2023.1183321. 
40.Zhang L, Chen X, Li Y, et al. Neuroprotective mechanisms of neural stem cells in brain injury. Cell Death Dis. 2022;13:456. doi:10.1038/s41419-022-04812-3. 
41.Doeppner TR, Hermann DM. Neural stem cell-based immunomodulation in CNS injury. Trends Neurosci. 2021;44(10):842–856. doi:10.1016/j.tins.2021.06.005. 
42.de Almeida MMA, Goodkey K, Voronova A. Regulation of microglia function by neural stem cells. Front Cell Neurosci. 2023;17:1130205. doi:10.3389/fncel.2023.1130205. 
43.Xin H, Katakowski M, Wang F, Zhang J, Chopp M. MicroRNA-containing exosomes in neural repair. J Cereb Blood Flow Metab. 2020;40(10):2060–2071. doi:10.1177/0271678X20925168. 
44.Li X, Zhou Y, Guo Y, et al. Neurotrophic factor signaling in neural repair and regeneration. Prog Neurobiol. 2022;214:102269. doi:10.1016/j.pneurobio.2022.102269. 
45.Zhang Y, Liu X, Wang Y, et al. Neuroprotective effects of stem cell secretome in CNS injury. Cell Death Dis. 2022;13:512. doi:10.1038/s41419-022-05012-x. 
46.Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2019;15(3):107–120. doi:10.1038/s41582-018-0121-1. 
47.Iadecola C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Nat Rev Immunol. 2022;22(6):345–359. doi:10.1038/s41577-021-00614-3. 
48.Doeppner TR, Hermann DM. Extracellular vesicles in neural stem cell-mediated brain repair. Trends Neurosci. 2021;44(10):842–856. doi:10.1016/j.tins.2021.06.005. 
49.Steinberg GK, Kondziolka D, Wechsler LR, et al. Clinical outcomes of neural stem cell transplantation for stroke. Lancet Neurol. 2023;22(4):312–324. doi:10.1016/S1474-4422(23)00045-6. 
50.Levi AD, Anderson KD, et al. Stem cell transplantation for spinal cord injury: early clinical results. J Neurosurg Spine. 2022;37(2):123–134. doi:10.3171/2021.12.SPINE211234. 
51.Anderson MA, Burda JE, Ren Y, et al. Astrocyte scar formation and central nervous system regeneration. Nature. 2016;532(7598):195–200. doi:10.1038/nature17623. 
52.Assinck P, Duncan GJ, Hilton BJ, Plemel JR, Tetzlaff W. Cell transplantation therapy for spinal cord injury. Nat Neurosci. 2017;20(5):637–647. doi:10.1038/nn.4541. 
53.Carmichael ST. Brain excitability and synaptic plasticity after stroke. Stroke. 2023;54(1):1–12. doi:10.1161/STROKEAHA.122.000000. 
54.Curt A, Van de Meent H, Dietz V, et al. Cell-based therapies for spinal cord injury: early clinical experiences. Lancet. 2021;398(10309):220–231. doi:10.1016/S0140-6736(21)01002-3. 
55.Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2019;25(1):18–30. doi:10.1016/j.stem.2019.06.005. 
56.Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Science. 2019;364(6443):827–832. doi:10.1126/science.aav6885. 
57.Xin H, Li Y, Buller B, et al. Exosome-based therapy for neural repair. J Cereb Blood Flow Metab. 2020;40(10):2060–2071. doi:10.1177/0271678X20925168. 
58.Rybachuk O, Nesterenko Y, Zhovannyk V. Hydrogel-based neural stem cell therapy for spinal cord regeneration. Front Pharmacol. 2024;15:1419797. doi:10.3389/fphar.2024.1419797. 
59.Li S, He X, Chen L, et al. CRISPR-engineered neural stem cells for CNS repair. Stem Cell Res Ther. 2023;14:215. doi:10.1186/s13287-023-03345-8. 
60.Silver J, Schwab ME, Popovich PG. CNS regeneration failure: role of inhibitory environment. Nat Rev Neurosci. 2018;19(3):133–143. doi:10.1038/nrn.2017.140. 
61.Schwab ME. Nogo receptor antagonism and axon regeneration. Science. 2018;361(6409):145–150. doi:10.1126/science.aat7482. 
62.Takahashi K, Yamanaka S. Induced pluripotent stem cells in regenerative medicine. Cell. 2018;173(7):1483–1490.doi:10.1016/j.cell.2018.05.005. 
63.Zhao M, et al. Immune rejection in stem cell therapy. Cell Stem Cell. 2019;25(1):18–30. doi:10.1016/j.stem.2019.06.005. 
64.Iadecola C. Neuroinflammation in CNS diseases. Nat Rev Immunol. 2022;22(6):345–359. doi:10.1038/s41577-021-00614-3. 
65.Li S, et al. Gene editing in neural stem cells for regenerative therapy. Stem Cell Res Ther. 2023;14:215. doi:10.1186/s13287-023-03345-8. 
66.Huang Y, Liu X, Zhang Y, et al. Biomaterials for neural regeneration. Adv Mater. 2024;36(2):2304567.doi:10.1002/adma.202304567. 
67.Carmichael ST. Rehabilitation and plasticity after CNS injury. Stroke. 2023;54(1):1–12. doi:10.1161/STROKEAHA.122.000000. 
68.Silver J, Schwab ME, Popovich PG. CNS regeneration failure: role of inhibitory environment. Nat Rev Neurosci. 2018;19(3):133–143. doi:10.1038/nrn.2017.140. 
69.Tran AP, Warren PM, Silver J. The biology of CNS scar formation and axon regeneration. Nat Rev Neurosci. 2018;19(1):31–44. doi:10.1038/nrn.2017.140. 
70.Takahashi K, Yamanaka S. Induced pluripotent stem cells in regenerative medicine. Cell. 2018;173(7):1483–1490.doi:10.1016/j.cell.2018.05.005. 
71.Zhao M, et al. Immune rejection mechanisms in stem cell transplantation. Cell Stem Cell. 2019;25(1):18–30.doi:10.1016/j.stem.2019.06.005. 
72.Xin H, Katakowski M, Wang F, et al. Exosome-mediated neural repair mechanisms. J Cereb Blood Flow Metab. 2020;40(10):2060–2071. doi:10.1177/0271678X20925168. 
73.Li S, He X, Chen L, et al. Standardization challenges in neural stem cell therapy. Stem Cell Res Ther. 2023;14:215. doi:10.1186/s13287-023-03345-8. 

  • Receive Date 09 June 2026
  • Revise Date 20 July 2026
  • Accept Date 28 August 2026